Notice Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor
페이지 정보
![profile_image](http://www.nihlungcancer.com/img/no_profile.gif)
작성자 최고관리자
조회 556회 작성일 22-03-16 14:22
조회 556회 작성일 22-03-16 14:22
본문
![](http://www.nihlungcancer.com/data/file/notice/1_copy_3_1794183271_mcDFQI0H_d3d6ba146d5f8e494050418017c08ba3fc384171.jpg)
Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor
[이 게시물은 최고관리자님에 의해 2022-03-16 15:07:26 News & Media에서 복사 됨]
[이 게시물은 최고관리자님에 의해 2022-03-16 15:08:04 News & Media에서 이동 됨]
[이 게시물은 최고관리자님에 의해 2022-03-16 15:08:38 Research에서 이동 됨]
- 이전글Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor 22.03.16
- 다음글Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor 22.03.16